While previous studies have identified HMGB1, TRL4, LY96, ANGPTL4, VEGFA, and IL10 as potential inflammation-related markers for AMS, the present study found that only HMGB1, LY96, and VEGFA were detectable, but not significantly differentially expressed. This evidence concerns the gene VEGFA and ablepharon macrostomia syndrome.